> CRO Pacific BioLabs has acquired Bay Bioanalytical Laboratory, folding analytical and bioanalytical chemistry into its in vivo preclinical and microbiological testing services. More
> Cytovance Biologics has inked a development and manufacturing deal with Fountain BioPharma for FB301, a novel monoclonal antibody. News
> Patheon ($PTI) has signed on with Pharmalink to manufacture the company's Nefecon treatment for nephropathy, which can lead to renal disease. Article
> Lonza is cutting 500 jobs at its API plant in Switzerland. Story
> Outsourcing-Pharma checked in with a few East Coast-based CMOs, all of which reported only minor damages from last week's hurricane. Report